English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

The effects of the neuroactive steroid 3α , 5α- THDOC on sleep in the rat

MPS-Authors

Müller-Preuss,  P
Max Planck Institute of Psychiatry, Max Planck Society;

Rupprecht,  R
Max Planck Institute of Psychiatry, Max Planck Society;

Lancel,  M
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Müller-Preuss, P., Rupprecht, R., & Lancel, M. (2002). The effects of the neuroactive steroid 3α, 5α- THDOC on sleep in the rat. NeuroReport, 13(4), 487-490.


Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-A22F-1
Abstract
This vehicle-controlled study assessed the sleep effects of the naturally occurring neuroactive steroid 3alpha 5alpha- tetrahydrodeoxycorticosterone (3alpha,5alpha-THDOC; 7.5 and 15 mg/kg), administered i.p. to rats, and compared them with those of another neuroactive steroid allopregnanolone (IS mg/kg). 3alpha,5alpha-THDOC shortened sleep latency, selectively promoted pre-REMS (a transitional state between non-REMS and REMS) and lengthened the non-REMS episodes dose-dependently. Spectral analysis of the EEG within nonREMS found significant attenuations of low-frequency activity and elevations in the spindle and higher frequency bands. The effects of 3alpha,5alpha-THDOC closely match those of allopregnanolone, indicating a common mechanism of action. Since the sleep changes produced by these steroids resemble the sleep profile of benzodiazepine hypnotics, they are probably caused by a positive allosteric modulation of GABA(A) receptor functi